Apple’s Beats brand brought the iconic Beats Pill back from the dead last summer. Now, the company is refreshing ...

The 2025 NFL Draft was low on action but high on intrigue as the first pick loomed. Not a single first-round pick was traded ...

TODAY Why Pfizer ended testing on once-daily weight-loss pill treatment Posted: April 15, 2025 | Last updated: April 15, 2025 Pfizer announced it is ending its development of a once-daily weight ...

A pill to treat obesity caused liver injury in ... Zepbound earned nearly $5 billion in 2024 alone, The Associated Press reported. But these drugs must be injected, which some folks don't want ...

The pill was in early testing to help determine the best dose, according to a Pfizer spokeswoman. The company had planned to move the drug into late-stage trials, typically the final step before ...

UNITED STATES – Pfizer is ending the development of its potential once-daily pill treatment for obesity ... brought in nearly $5 billion in sales in 2024, its first full year on the market.

Danuglipron, a weight-loss pill, won’t continue its stages of testing ... Eli Lilly and Co.’s Zepbound raked in almost $5 billion in sales last year. RELATED: Fake Wegovy and Ozempic ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to a study published Monday in The Lancet. If approved, it would become ...

Pfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial. The patient ...